Regarding HRAS mutant cancer cells, the downregulated pathways via Kegg enrichment analysis included Wnt signaling, hypoxia-inducible factor 1 (HIF-1) signaling, glucagon signaling, Prolactin signaling, and Hippo signaling, among others. This evidence concerns the gene HRAS and cancer.